Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alsius was a medical technology company that developed and marketed proprietary intravascular temperature management (IVTM) systems. The company's technology allowed for precise control of a patient's core body temperature through a heat-exchange catheter inserted into the venous system. These systems were primarily used in critical care settings to manage fever or induce therapeutic hypothermia in patients suffering from cardiac arrest, stroke, or traumatic brain injury. Alsius's product portfolio included the CoolGard and Thermogard consoles along with specialized catheters like the Quattro and Icy. The company went public in 2007 but was subsequently acquired by ZOLL Medical Corporation in 2009. Following the acquisition, Alsius's technology was integrated into ZOLL's temperature management division, where it continues to be a market leader.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alsius.